The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics-Reference-Cited by-同舟云学术

The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics

Published:2014-07-24 Issue: Volume:4 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Hammond Edward,Khurana Ashwani,Shridhar Viji,Dredge Keith

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference169 articles.

1. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor;Kim;J Endocrinol,2011

2. The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors;SzatmÃ¡ri;Front Oncol,2013

3. Syndecans as modulators and potential pharmacological targets in cancer progression;Barbouri;Front Oncol,2014

4. Heparan sulfate and heparanase as modulators of breast cancer progression;Gomes;Biomed Res Int,2013

5. The heparanase/syndecan-1 axis in cancer: mechanisms and therapies;Ramani;FEBS J,2013

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID‐19 vaccine adverse events: Evaluating the pathophysiology with an emphasis on sulfur metabolism and endotheliopathy;European Journal of Clinical Investigation;2024-08-08

2. Glycosylation of FGF/FGFR: An underrated sweet code regulating cellular signaling programs;Cytokine & Growth Factor Reviews;2024-06

3. CircNSD1 promotes cardiac fibrosis through targeting the miR-429-3p/SULF1/Wnt/β-catenin signaling pathway;Acta Pharmacologica Sinica;2024-05-17

4. miRNA profiling of esophageal adenocarcinoma using transcriptome analysis;Cancer Biomarkers;2024-03-14

5. Heparanase interacting BCLAF1 to promote the development and drug resistance of ICC through the PERK/eIF2α pathway;Cancer Gene Therapy;2024-03-11